Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Adiantum capillus-veneris aqueous extract is a botanical preparation derived from the Southern Maidenhair fern, a plant widely used in traditional medicine systems such as Unani and Ayurveda. The extract is rich in phytochemicals, including flavonoids (quercetin, kaempferol), triterpenoids (adiantone), and proanthocyanidins, which contribute to its pharmacological profile. It is primarily recognized for its antitussive, anti-inflammatory, and antioxidant activities. Clinical research has focused on its potential in managing respiratory conditions like asthma and chronic bronchitis, as well as endocrine disorders such as Polycystic Ovary Syndrome (PCOS) and dermatological conditions like androgenetic alopecia. Its mechanism of action involves the inhibition of pro-inflammatory cytokines and the neutralization of reactive oxygen species.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on adiantum capillus-veneris aqueous extract.